TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 66 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2014. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $124,000 | -75.7% | 109,800 | -40.6% | 0.00% | -60.0% |
Q3 2018 | $510,000 | +78.9% | 184,800 | +131.6% | 0.01% | +66.7% |
Q2 2018 | $285,000 | +16.3% | 79,800 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $245,000 | -51.3% | 79,800 | 0.0% | 0.00% | -40.0% |
Q4 2017 | $503,000 | -7.9% | 79,800 | 0.0% | 0.01% | -16.7% |
Q3 2017 | $546,000 | -4.0% | 79,800 | 0.0% | 0.01% | -14.3% |
Q2 2017 | $569,000 | -60.0% | 79,800 | -48.4% | 0.01% | -58.8% |
Q1 2017 | $1,423,000 | +25.7% | 154,800 | -44.9% | 0.02% | +13.3% |
Q4 2016 | $1,132,000 | +5.2% | 280,900 | 0.0% | 0.02% | -6.2% |
Q3 2016 | $1,076,000 | -30.8% | 280,900 | -22.3% | 0.02% | -33.3% |
Q2 2016 | $1,555,000 | +29.0% | 361,717 | +1324.1% | 0.02% | 0.0% |
Q2 2015 | $1,205,000 | -34.2% | 25,400 | -49.2% | 0.02% | -36.8% |
Q1 2015 | $1,832,000 | -7.8% | 50,000 | 0.0% | 0.04% | -15.6% |
Q4 2014 | $1,986,000 | +99.0% | 50,000 | 0.0% | 0.04% | +80.0% |
Q3 2014 | $998,000 | +47.9% | 50,000 | 0.0% | 0.02% | +38.9% |
Q2 2014 | $675,000 | – | 50,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 354,300 | $7,068,000 | 2.77% |
Opaleye Management Inc. | 169,700 | $3,385,515,000 | 2.64% |
Broadfin Capital, LLC | 959,247 | $19,137,000 | 2.01% |
Novo Holdings A/S | 900,000 | $17,955,000 | 1.75% |
Eventide Asset Management | 300,900 | $6,003,000 | 0.84% |
EAM Investors, LLC | 152,595 | $3,044,000 | 0.62% |
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 497,858 | $9,932,000 | 0.51% |
Granite Point Capital Management, L.P. | 40,000 | $798,000 | 0.40% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,191 | $8,981,000 | 0.33% |
TFS CAPITAL LLC | 133,070 | $2,655,000 | 0.23% |